Randomised trial of interferon [small alpha, Greek]2b plus ribavirin for 48 weeks or for 24 weeks versus interferon [small alpha, Greek]2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

    loading  Checking for direct PDF access through Ovid

Abstract

Lancet 1998; 352

1426-32

Related Topics

    loading  Loading Related Articles